Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€485.05
23.11.20
€770.00
07.07.23
39.47%
25.05.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€485.05
23.11.20
€770.00
07.07.23
39.47%
25.05.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€485.05
23.11.20
€770.00
07.07.23
39.47%
25.05.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
ROE higher than 15% per year
buy
Plastic Omnium S.A.

Start price
Target price
Perf. (%)
€24.18
22.11.20
€28.00
22.11.21
0.17%
23.11.21

Could be worthwhile Investment >10% per year
buy
Energiekontor

Start price
Target price
Perf. (%)
€43.10
22.11.20
€60.00
22.11.21
89.33%
23.11.21

Could be worthwhile Investment >10% per year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€450.00
-25.76%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€450.00
-25.76%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€450.00
-25.76%
11.12.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Bayer AG

Start price
Target price
Perf. (%)
€48.20
22.11.20
€73.00
22.11.21
-0.41%
23.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Very high dividend yield expected
buy
Bayer AG

Start price
Target price
Perf. (%)
€48.20
22.11.20
€73.00
22.11.21
-0.41%
23.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Very high dividend yield expected
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

buy
Citizens Financial

Start price
Target price
Perf. (%)
€27.20
21.11.20
-
21.11.21
15.44%
22.01.21

Revenue growth >5% per year expected
EBIT decline/stagnation expected
buy
Groupe SFPI S.A.

Start price
Target price
Perf. (%)
€1.66
21.11.20
€3.80
21.11.21
108.16%
24.10.21

Could be worthwhile Investment >10% per year
Inovio Pharma

Start price
Target price
Perf. (%)
€8.95
21.11.20
-
21.11.21
28.49%
10.02.21

Could be worthwhile Investment >10% per year
High risks for its business
Dependend from few customers or products
buy
Apple Inc.

Start price
Target price
Perf. (%)
€99.28
20.11.20
€130.00
20.11.21
25.18%
21.07.21

Could be very worthwhile Investment >20% year
buy
Apple Inc.

Start price
Target price
Perf. (%)
€99.28
20.11.20
€130.00
20.11.21
25.18%
21.07.21

Could be very worthwhile Investment >20% year
buy
Apple Inc.

Start price
Target price
Perf. (%)
€99.28
20.11.20
€130.00
20.11.21
25.18%
21.07.21

Could be very worthwhile Investment >20% year
buy
Apple Inc.

Start price
Target price
Perf. (%)
€99.28
20.11.20
€130.00
20.11.21
25.18%
21.07.21

Could be very worthwhile Investment >20% year
buy
SPI Energy Co Ltd ADR

Start price
Target price
Perf. (%)
€9.20
20.11.20
€11.00
20.11.21
-27.72%
10.12.20

Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year
buy
Starbucks Corp.

Start price
Target price
Perf. (%)
€82.11
20.11.20
-
2.28%
17.12.20

buy
Starbucks Corp.

Start price
Target price
Perf. (%)
€82.11
20.11.20
-
2.28%
17.12.20

buy
Starbucks Corp.

Start price
Target price
Perf. (%)
€82.11
20.11.20
-
2.28%
17.12.20

buy
Teleflex Inc.

Start price
Target price
Perf. (%)
€308.00
20.11.20
-
20.11.21
8.44%
14.02.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected